Featured Education

nmdp-mds3_1729518959
soho-2024-enduring-banner-445x250-02-02-02_1727985795
p24011-lms-thumb_1726675197
P23033 LMS Thumb
p24034-obesity-aafp-lms-thumbnail-445x250px_1723738749
lms-thumbnail-445-x-250_1720799794

On Demand Activities

More results...

Therapeutics Areas
Learner Specialties
Expires After
  • On-Demand
Keeping Up with CAR T-cell Therapy: A Case-based Challenge of CART in NHL + MM
  • Credit: 1.50hr(s)
  • ILNA, NCPD
  • May 15, 2024 — 
  • May 14, 2025
  • Therapeutic Areas: Hematologic Oncology, Hematology, Oncology
  • Specialties: Hematology, Lymphoma, Oncology
  • Location: Internet Activity Enduring
Nurses are often at the front lines of clinical care and as such, are perfectly positioned to bridge the gap between evolving clinical evidence and patient-centered care in Non-Hodgkin’s Lymphoma (NHL) and Multiple Myeloma (MM). This dynamic educational activity will equip nursing professionals with the critical skills to integrate the latest advancements in CAR T-cell therapy into practice, ensuring alignment with NCCN guidelines and patient preferences. Through interactive case studies and expert-led discussions, you’ll be empowered to manage complex treatment scenarios, deliver comprehensive patient education, and navigate even the trickiest treatment-related challenges.
Access Course
  • On-Demand
Improving Survival in First-Line Metastatic NSCLC with Dual Checkpoint Blockade: Exploring Recent Data and Treatment Strategies / Activity 1
  • Credit: 0.50hr(s)
  • AAPA, CME, CPE, NCPD
  • February 17, 2023 — 
  • September 30, 2024
  • Therapeutic Areas: Hematologic Oncology, Oncology
  • Specialties: NSCLC, Oncology
  • Location: Internet Activity Enduring
This educational initiative is designed for community-based oncology clinicians (physicians, nurse practitioners [NPs], physician assistants [PAs], pharmacists, and nurses) to enhance outcomes for individuals with who provide care for individuals with mNSCLC. This interactive online activity uses the game-based platform Kahoot! to test participant ability to identify and apply key learning points while competing against their colleagues. Expert faculty will discuss the emerging efficacy and safety data for CTLA-4 inhibitor combination regimens in metastatic NSCLC (mNSCLC) and explore strategies to identify patients who would most benefit from these therapies through the use of biomarkers. Additionally, there will be an in-depth discussion regarding approaches to effectively collaborate with other clinicians and mNSCLC patients to provide cost-effective, equitable, and inclusive care for patients of all socioeconomic and racial/ethnic backgrounds. Join us for Part 2 of this question and answer based educational activity, Improving Survival in First-line Metastatic NSCLC with Dual Checkpoint Blockade: Real-world Applications in Clinical Practice to apply the evidence to real-world patient cases!
Access Course
  • On-Demand
Transforming Relapsed/Refractory MCL: Exploring New Options for Your Patients
  • Credit: 1.0hr(s)
  • CME, EBAH, ECMEC
  • June 28, 2023 — 
  • June 28, 2024
  • Therapeutic Areas: Hematologic Oncology, Hematology, Oncology
  • Specialties: Lymphoma, Mantle Cell Lymphoma
  • Location: Internet Activity Enduring
Treatment for R/R MCL is complicated, as the disease typically presents in elderly, unfit patients; however, emerging targeted therapy options have shown great promise based on excellent results in clinical trials. In this activity, a taped version of the live symposium at the 17th Annual International Conference on Malignant Lymphoma, expert faculty present therapeutic options, established by evidence-based practice guidelines, for patients with R/R MCL. Symposium learners voted on patient demographics and parameters such as treatment, dosing frequency, and adverse events. The experts crafted their lecture to follow thheir suggestions allowing the case studies to reflect the patients the learners see. The activity concludes with a discussion on engagement between healthcare providers and patients to improve clinical outcomes.
Access Course
  • On-Demand
Metastatic Breast Cancer Retreats: Value to the Patient and Your Multidisciplinary Team
  • Credit: 0.50hr(s)
  • CME
  • September 16, 2024 — 
  • September 15, 2025
  • Therapeutic Areas: Oncology
  • Specialties: Breast Cancer
  • Location: Internet Activity Enduring
Why Your Patients Should Attend a Metastatic Breast Cancer Retreat and the Value it also provides to you and your multi-disciplinary team. This video will demonstrate some of the activities that take place at a MBC retreat and the lessons learned from them.
Access Course
  • On-Demand
New Horizons in Multiple Myeloma Treatment: The Promise of CAR-T for Early Relapsed Disease
  • Credit: 1.00hr(s)
  • AAPA, CME, CPE, IPCE, NCPD
  • May 31, 2023 — 
  • May 30, 2024
  • Therapeutic Areas: Hematologic Oncology, Hematology, Oncology
  • Specialties: CAR T-Cell Therapy, Multiple Myeloma
  • Location: Internet Activity Enduring
Despite remarkable progress, significant gaps remain in meeting the needs of patients facing relapse in multiple myeloma, particularly among patients with early relapse or triple-class exposed disease. Join us for a groundbreaking Special Edition Med Table Talk episode where we delve into the latest advancements in the treatment of relapsed multiple myeloma (RRMM).  This candid conversation between esteemed faculty experts discusses the latest clinical evidence and rationale for CAR T-cell therapy in early versus late relapse settings and embraces a future pathway where highly effective treatments may be delivered earlier to support increasingly durable responses for complex patient populations.
Access Course
  • On-Demand
The Difference Between Palliative and Hospice Care
  • Credit: 0.25hr(s)
  • CME
  • September 16, 2024 — 
  • September 15, 2025
  • Therapeutic Areas: Oncology
  • Specialties: Breast Cancer
  • Location: Internet Activity Enduring
The Difference between Palliative Care and Hospice that result in Barriers to Care. What you will learn from this module:   Learn the assumptions and perceptions patients and their families have about the purpose of transitioning to hospice care. Understand the myths associated with agreeing to receive palliative care. Understand that palliative care stands alone and should be part of a patient’s care from the beginning when they are diagnosed with advanced cancer. Learn the barriers to implementing palliative care. Learn the value of palliative care when delivering patient centered care. Learn about how palliative care is also part of hospice care.
Access Course
View All MLI Activities
Facebook Twitter Linkedin Instagram
Subscribe to Mailing List
Scroll to Top